Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment

Hajer Ziouziou; Claudia Andrieu; Erik Laurini; Sara Karaki; Maurizio Fermeglia; Ridha Oueslati; David Taieb; Michel Camplo; Olivier Siri; Sabrina Pricl; Maria Katsogiannou; Palma Rocchi

doi:10.18632/oncotarget.25683

Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment

Oncotarget. 2018 Jun 19;9(47):28797. doi: 10.18632/oncotarget.25683.

Authors

Hajer Ziouziou^{1

2

3

4

5}, Claudia Andrieu^{1

2

3

4}, Erik Laurini^{6

7}, Sara Karaki^{1

2

3

4}, Maurizio Fermeglia^{6

7}, Ridha Oueslati⁵, David Taieb^{1

2

3

4}, Michel Camplo⁷, Olivier Siri⁸, Sabrina Pricl^{6

7}, Maria Katsogiannou^{1

2

3

4}, Palma Rocchi^{1

2

3

4}

Affiliations

¹ Inserm, UMR1068, CRCM, Marseille, France.
² Institut Paoli-Calmettes, Marseille, France.
³ Aix-Marseille Université, Marseille, France.
⁴ CNRS, UMR7258, CRCM, Marseille, France.
⁵ Unit of Immunology Microbiology Environmental and Carcinogenesis (IMEC), Science Faculty of Bizerte, University of Carthage, Bizerte, Tunisia.
⁶ Molecular Simulation Engineering (MOSE) Laboratory, DEA, University of Trieste, Trieste, Italy.
⁷ National Interuniversity Consortium for Material Science and Technology (INSTM), Research Unit MOSE-DEA, University of Trieste, Trieste, Italy.
⁸ Aix-Marseille Université, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Marseille, France.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.20469.].

Publication types

Published Erratum